HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mimi Guarneri Selected Research

xemilofiban

4/2009Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).
11/2008Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mimi Guarneri Research Topics

Disease

1Hyperglycemia
06/2019
1Abdominal Obesity
06/2019
1Hypertriglyceridemia
06/2019
1Hypertension (High Blood Pressure)
06/2019
1Inflammation (Inflammations)
06/2019
1Insulin Resistance
06/2019
1Cardiovascular Diseases (Cardiovascular Disease)
12/2009
1Hemorrhage
04/2009
1Myocardial Infarction
04/2009
1Proteinuria
11/2008
1Body Weight (Weight, Body)
01/2003

Drug/Important Bio-Agent (IBA)

2LipidsIBA
12/2009 - 01/2003
2xemilofibanIBA
04/2009 - 11/2008
1HDL LipoproteinsIBA
06/2019
1Glycoproteins (Glycoprotein)IBA
04/2009

Therapy/Procedure

2Percutaneous Coronary Intervention
04/2009 - 11/2008
1Blood Transfusion (Blood Transfusions)
04/2009